Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2005
08/10/2005CN1651580A Patch for microarray reaction chamber having adhesive means support and two or more adhesive materials
08/10/2005CN1651577A Conditionally replicating viral vectors and their use
08/10/2005CN1651576A Production method and process of recombination chicken beta-alexin
08/10/2005CN1651575A Structure of antisense digonucleotide for inhibiting fibronectin expression and use
08/10/2005CN1651571A Super engineering bactrerin, its expressed detoxicating enzyme, construction method and application
08/10/2005CN1651570A Recombinated multi shape ttansenula yeast, its structural method and application
08/10/2005CN1651459A Small salt mustard sodium hydrogen pump protein gene TNHX1 and its anti salt application
08/10/2005CN1651458A Antigenic proteins of shrimp white spot syndrome virus and uses thereof
08/10/2005CN1651457A Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens
08/10/2005CN1651080A Method of preparing rabies live carrier vaccine using gland virus carrier expression rabies virus bigene
08/10/2005CN1214244C Immuno assay solid-phase supporter, reagent kit, preparation and use thereof
08/10/2005CN1214116C Method for breeding transgene paddy rice without choice mark by using dual T-DNA carrir
08/10/2005CN1214115C Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
08/10/2005CN1214114C Activatable recombinant neurotoxins
08/10/2005CN1214113C Gene sequence of Japanese shistosome China mainland strain gynecophoric canal protein
08/10/2005CN1214111C Method for detecting qualitative and quantitative alterations in DNA and ligands
08/10/2005CN1214110C Cassava vein mosaic virus promoters and uses thereof
08/10/2005CN1214107C Enterpeptidase light chain variant with high activity and high stability
08/10/2005CN1214105C MAP kinase phosphatase mutant
08/10/2005CN1214044C ErdB3 antibodies
08/10/2005CN1214043C Humanized antibodies to gamma-interferon
08/10/2005CN1214041C Signal sequence trapping method
08/10/2005CN1213768C Method of treating endotoxemia
08/10/2005CA2496146A1 Stabilization of linear double-stranded dna in the presence of exonucleases
08/09/2005US6928368 Gene mining system and method
08/09/2005US6927322 Cabbage proteinase inhibitor gene confers resistance against plant pests
08/09/2005US6927321 Transformed soybean plant cell containing a nucleic acid molecule, a promoter heterologous with respect to the structural nucleic acid sequence
08/09/2005US6927320 A transgenic plant comprising a transgene, able expressing specifically in root progenitor tissues of embryos, coding herbicide, pathogen, or insect resist gene products, increase biosynthesis of starch, lignan or cellulose
08/09/2005US6927317 Modulating ramp activity
08/09/2005US6927288 Plant thermogenic genes and proteins
08/09/2005US6927286 Encoding the first identified hybrid polyketide synthase/nonribosomal peptide synthetase pathway
08/09/2005US6927285 Genes for human telomerase reverse transcriptase and telomerase variants
08/09/2005US6927283 Modified acyl carrier proteins
08/09/2005US6927281 isolated monoclonal antibody directed against an AAV type 2 capsid or protein, capable of detection in an ELISA assay, immunofluorescence or Western blotting
08/09/2005US6927280 Cocoa albumin and its use in the production of cocoa and chocolate flavor
08/09/2005US6927279 Prevention infections in cattle; vaccines; therapy for thrombosis
08/09/2005US6927278 Exploiting endogenous import and export mechanisms of ribonucleic acid trafficking which utilize nuclear targeting peptides containing nonclassical nuclear localization signals
08/09/2005US6927213 For delivering biologically active substances to cells and for transfecting nucleic acids into cells
08/09/2005US6927207 polypeptides; cell recognition molecule which couples to the polypeptide, wherein the cell recognition molecule selectively binds to target cells; antitumor agents; used for example as a prophylactic against relapse after surgical tumour removal
08/09/2005US6927065 Determining velocity of elongated biopolymer; classify segment of biopolymer, transfer biopolymer through detection zones, monitor signal amplitude, measure signal amplitude profiles, analyze signal to determine biopolymer velocity
08/09/2005US6927059 Compositions and methods for identifying agents which regulate autolytic processes in bacteria
08/09/2005US6927057 Macrolide analogs
08/09/2005US6927056 Proteases
08/09/2005US6927055 Genetic engineered Dna; textile cleaning compounds
08/09/2005US6927054 Peptide for use in the diagnosis, prevention, and treatment of inflammation, cancer, arteriosclerosis and degenerative defects
08/09/2005US6927046 Increased lysine production by gene amplification using coryneform bacteria
08/09/2005US6927045 Methods and apparatus for template capture and normalization for submicroliter reaction
08/09/2005US6927044 IL-1 receptor based cytokine traps
08/09/2005US6927043 Cancer therapy
08/09/2005US6927041 Human neuropeptide Y-like G protein-coupled receptor
08/09/2005US6927040 Polpeptide for use in the treatment of granulomatosis, nervous system and skin disorders, bacterial infections and leishmania
08/09/2005US6927035 Antigens used for medical diagnosis of dihydropyrimidine dehydrogenase (DPD) deficiency
08/09/2005US6927034 Diagnosing pregnancy in humans; obtain sample, incubate with antibody, monitor complex formation, presence of complex indicates pregnancy
08/09/2005US6927032 Expression monitoring by hybridization to high density oligonucleotide arrays
08/09/2005US6927028 Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
08/09/2005US6927027 Nucleic acid multiplex formation
08/09/2005US6927026 Orotidine-5′-phosphate decarboxylase-gene, gene construct containing said gene and the utilization thereof
08/09/2005US6927025 generating gene or dna libraries, sequencing polypeptides and analyzing them for cell binding
08/09/2005US6926898 Albumin fusion proteins
08/09/2005US6926894 For the prophylaxis or therapy of thrombosis and thromboembolic diseases
08/09/2005US6926893 Multi-stage cascade boosting vaccine
08/09/2005CA2362431C Methods of using viral replicase
08/09/2005CA2289665C Protein recovery by chromatography followed by filtration upon a charged layer
08/09/2005CA2186764C High-alkaline protease and its use
08/09/2005CA2150346C Anti-feline herpes virus-1 recombinant antibody and gene fragment coding for said antibody
08/09/2005CA2145400C Biotechnological method of producing biotin
08/09/2005CA2117668C Recombinant adenovirus and process for producing the same
08/09/2005CA2019676C Particle-mediated transformation of animal somatic cells
08/09/2005CA2012778C Disease-resistant transgenic plants
08/06/2005CA2553946A1 Antibodies against clostridium difficile toxins and uses thereof
08/04/2005WO2005071414A2 Kit for immobilizing organic substance, organic substance-immobilized structure, and manufacturing methods therefor
08/04/2005WO2005071105A1 An essential hypertension associated gene and the detecting method and the usage thereof
08/04/2005WO2005071098A1 Method of screening substance improving lipid metabolism
08/04/2005WO2005071093A2 Chimpanzee adenovirus vaccine carriers
08/04/2005WO2005071092A1 METHOD OF PRODUCING MINUS STRAND RNA VIRUS VECTOR WITH THE USE OF HYBRID PROMOTER CONTAINING CYTOMEGALOVIRUS ENHANCER AND AVIAN β-ACTIN PROMOTER
08/04/2005WO2005071091A1 Method for modifying gene expression of a phytopathogenic fungus
08/04/2005WO2005071090A1 Two-component rna virus-derived plant expression system
08/04/2005WO2005071089A2 Dual host expression vector system and screening methods
08/04/2005WO2005071087A1 Method for producing carotenoids and bacteria used therefor
08/04/2005WO2005071086A1 Method for the genetic modulation of the biosynthesis of hemicelluloses, cellulose and uronic acids in plant cells using gene expression cassettes
08/04/2005WO2005071085A1 Process for producing virus vector
08/04/2005WO2005071084A1 Construction of gutted recombinant adenovirus effectively expressing antibodies comprising human constant region and uses thereof
08/04/2005WO2005071083A1 An arabidopis thaliana transcription factoras well as the encoding gene and the use thereof
08/04/2005WO2005071082A1 Antisense oligonucleotide having anticancerous activity
08/04/2005WO2005071081A1 Eosinophil-deficient transgenic animals
08/04/2005WO2005071080A2 Modulation of glucocorticoid receptor expression
08/04/2005WO2005071079A1 Inhibitors of mammalian hdac 11 useful for treating hdac 11 mediated disorders
08/04/2005WO2005071078A1 Method of performing pcr amplification on a microarray
08/04/2005WO2005071077A1 De novo enzymatic production of nucleic acid molecules
08/04/2005WO2005071074A1 Transformed saccharomyces cerevisiae and method for mass-production of lk8 protein using the same
08/04/2005WO2005071072A1 The recombinant murine leukemia virus reverse transcriptase, the gene encoding it and the method for expressing it
08/04/2005WO2005071071A1 Ptd-human choline acetyltransferase fusion protein and its application
08/04/2005WO2005070967A2 Anti-cancer antibodies with reduced complement fixation
08/04/2005WO2005070948A1 Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated rna trans splicing
08/04/2005WO2005070469A1 Methods of treating mesothelioma using an antisense oligonucleotide to thymidylate synthase
08/04/2005WO2005070459A1 Method of continuing expression of vector repeatedly administered
08/04/2005WO2005070214A2 Peptides for inhibiting insects
08/04/2005WO2005070199A1 Mouse model for psoriasis and psoriatic arthritis
08/04/2005WO2005070195A1 Transgenic plant having increased seed weight and utilization thereof
08/04/2005WO2005070122A2 Mechanosensitive ion channels and methods of use